RA Capital Management - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 51 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RA Capital Management ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$33,768,000
+37.6%
2,415,4580.0%1.46%
+2.0%
Q4 2018$24,541,000
+505.1%
2,415,458
+581.9%
1.43%
+186.7%
Q1 2017$4,056,000
-1.7%
354,2000.0%0.50%
-14.9%
Q4 2016$4,126,000
-13.0%
354,2000.0%0.58%
+19.6%
Q3 2016$4,743,000
-18.0%
354,200
+21.4%
0.49%
-38.9%
Q2 2016$5,781,000
+18.2%
291,7000.0%0.80%
+28.0%
Q1 2016$4,892,000291,7000.62%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Simplify Asset Management Inc. 2,700,000$823,5000.09%
683 Capital Management, LLC 2,650,000$808,2500.06%
GSA CAPITAL PARTNERS LLP 355,867$1090.01%
RBF Capital, LLC 391,265$119,3360.01%
UBS OCONNOR LLC 393,975$120,1620.00%
XTX Topco Ltd 15,597$4,7570.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 106,700$32,5440.00%
AMERIPRISE FINANCIAL INC 8,592,471$2,620,7040.00%
DRW Securities, LLC 120,365$370.00%
DFPG INVESTMENTS, LLC 32,430$10,8960.00%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders